ANTIFUNGAL NANOPARTICLES FOR TARGETED TREATMENT OF FUNGAL INFECTIONS

The invention provides functionalized antifungal-loaded liposomal formulations targeting Candida, which minimize damage to healthy human cells, limit antimicrobial exposure, and reduce the development of antifungal resistance..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 26. Mai Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

SHUKLA ANITA [VerfasserIn]
COWLES SARAH [VerfasserIn]
VERA-GONZALEZ NOEL [VerfasserIn]
BAILEY-HYTHOLT CHRISTINA [VerfasserIn]
SILVERT ELI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-05-26, Last update posted on www.tib.eu: 2022-09-12, Last updated: 2023-02-09

Patentnummer:

US2022160631

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA01357003X